Literature DB >> 33922748

New Sequence Type ST3449 in Multidrug-Resistant Pseudomonas aeruginosa Isolates from a Cystic Fibrosis Patient.

Catalina Díaz-Ríos1, Marta Hernández2, David Abad2, Laura Álvarez-Montes1, Athanasia Varsaki3, David Iturbe4, Jorge Calvo5, Alain A Ocampo-Sosa1,5.   

Abstract

Pseudomonas aeruginosa is one of the most critical bacterial pathogens associated with chronic infections in cystic fibrosis patients. Here we show the phenotypic and genotypic characterization of five consecutive multidrug-resistant isolates of P. aeruginosa collected during a month from a CF patient with end-stage lung disease and fatal outcome. The isolates exhibited distinct colony morphologies and pigmentation and differences in their capacity to produce biofilm and virulence potential evaluated in larvae of Galleria mellonella. Whole genome-sequencing showed that isolates belonged to a novel sequence type ST3449 and serotype O6. Analysis of their resistome demonstrated the presence of genes blaOXA-396, blaPAO, aph(3')-IIb, catB, crpP and fosA and new mutations in chromosomal genes conferring resistance to different antipseudomonal antibiotics. Genes exoS, exoT, exoY, toxA, lasI, rhlI and tse1 were among the 220 virulence genes detected. The different phenotypic and genotypic features found reveal the adaptation of clone ST3449 to the CF lung environment by a number of mutations affecting genes related with biofilm formation, quorum sensing and antimicrobial resistance. Most of these mutations are commonly found in CF isolates, which may give us important clues for future development of new drug targets to combat P. aeruginosa chronic infections.

Entities:  

Keywords:  Pseudomonas aeruginosa; biofilm; cystic fibrosis; multi-drug resistance; sequence type ST3449; virulence

Year:  2021        PMID: 33922748     DOI: 10.3390/antibiotics10050491

Source DB:  PubMed          Journal:  Antibiotics (Basel)        ISSN: 2079-6382


  102 in total

1.  [Survey of the antibiotic sensitivity of Pseudomonas aeruginosa in France and the distribution of beta-lactam resistance mechanisms: the GERPB 1999 study].

Authors:  J D Cavallo; F Leblanc; R Fabre; A Fourticq-Esqueöute
Journal:  Pathol Biol (Paris)       Date:  2001-09

2.  Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients.

Authors:  Eric E Smith; Danielle G Buckley; Zaining Wu; Channakhone Saenphimmachak; Lucas R Hoffman; David A D'Argenio; Samuel I Miller; Bonnie W Ramsey; David P Speert; Samuel M Moskowitz; Jane L Burns; Rajinder Kaul; Maynard V Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-10       Impact factor: 11.205

3.  Biofilm Formation and Quorum-Sensing-Molecule Production by Clinical Isolates of Serratia liquefaciens.

Authors:  Sara Remuzgo-Martínez; María Lázaro-Díez; Celia Mayer; Maitane Aranzamendi-Zaldumbide; Daniel Padilla; Jorge Calvo; Francesc Marco; Luis Martínez-Martínez; José Manuel Icardo; Ana Otero; José Ramos-Vivas
Journal:  Appl Environ Microbiol       Date:  2015-03-06       Impact factor: 4.792

4.  Molecular genetic analysis of an XDR Pseudomonas aeruginosa ST664 clone carrying multiple conjugal plasmids.

Authors:  Zhenpeng Li; Zhao Cai; Zeqiong Cai; Yanhong Zhang; Tongtong Fu; Yongxin Jin; Zhihui Cheng; Shouguang Jin; Weihui Wu; Liang Yang; Fang Bai
Journal:  J Antimicrob Chemother       Date:  2020-06-01       Impact factor: 5.790

Review 5.  Structure and function of OprD protein in Pseudomonas aeruginosa: from antibiotic resistance to novel therapies.

Authors:  Hui Li; Yi-Feng Luo; Bryan J Williams; Timothy S Blackwell; Can-Mao Xie
Journal:  Int J Med Microbiol       Date:  2012-01-05       Impact factor: 3.473

6.  Identification of Essential Residues for Ciprofloxacin Resistance of Ciprofloxacin-Modifying Enzyme (CrpP) of pUM505.

Authors:  Víctor M Chávez-Jacobo; Juan Pablo García Merinos; Yliana López; Victor Meza-Carmen; Martha I Ramírez-Díaz
Journal:  Microbiology (Reading)       Date:  2020-01-28       Impact factor: 2.777

7.  Phenotypic and genotypic characterization of Pseudomonas aeruginosa from cystic fibrosis patients.

Authors:  I Leone; M G Chirillo; T Raso; M Zucca; D Savoia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-05-17       Impact factor: 3.267

Review 8.  Pseudomonas aeruginosa Diversification during Infection Development in Cystic Fibrosis Lungs-A Review.

Authors:  Ana Margarida Sousa; Maria Olívia Pereira
Journal:  Pathogens       Date:  2014-08-18

9.  Draft Genome Sequences of Two Pseudomonas aeruginosa Multidrug-Resistant Clinical Isolates, PAL0.1 and PAL1.1.

Authors:  Teddy Grandjean; Rémi Le Guern; Claire Duployez; Karine Faure; Eric Kipnis; Rodrigue Dessein
Journal:  Microbiol Resour Announc       Date:  2018-11-01

10.  Within-Host Evolution of the Dutch High-Prevalent Pseudomonas aeruginosa Clone ST406 during Chronic Colonization of a Patient with Cystic Fibrosis.

Authors:  Rosa van Mansfeld; Mark de Been; Fernanda Paganelli; Lei Yang; Marc Bonten; Rob Willems
Journal:  PLoS One       Date:  2016-06-23       Impact factor: 3.240

View more
  1 in total

1.  Detection of Pseudomonas aeruginosa Serogroup G Using Real-Time PCR for Novel Target Genes Identified Through Comparative Genomics.

Authors:  Chufang Wang; Qinghua Ye; Yu Ding; Jumei Zhang; Qihui Gu; Rui Pang; Hui Zhao; Juan Wang; Qingping Wu
Journal:  Front Microbiol       Date:  2022-06-24       Impact factor: 6.064

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.